160 related articles for article (PubMed ID: 38643139)
21. PEComa-like Neoplasms Characterized by ASPSCR1-TFE3 Fusion: Another Face of TFE3-related Mesenchymal Neoplasia.
Argani P; Wobker SE; Gross JM; Matoso A; Fletcher CDM; Antonescu CR
Am J Surg Pathol; 2022 Aug; 46(8):1153-1159. PubMed ID: 35848761
[TBL] [Abstract][Full Text] [Related]
22. [Detection of ASPL-TFE3 fusion gene by reverse transcriptase polymerase chain reaction in paraffin-embedded tumor tissues of alveolar soft part sarcoma].
Pang LJ; Li F; Chang B; Hu WH; Lu TC; Li XX; Li HA; Jiang JF
Zhonghua Bing Li Xue Za Zhi; 2004 Dec; 33(6):508-12. PubMed ID: 15634444
[TBL] [Abstract][Full Text] [Related]
23. Is immunohistochemistry always the panacea to morphologic mimics? Two, distinct soft tissue tumors exhibiting alveolar pattern and TFE3 immunoreactivity.
Shah A; Rekhi B; Patil A
Indian J Pathol Microbiol; 2021; 64(4):767-770. PubMed ID: 34673600
[TBL] [Abstract][Full Text] [Related]
24. Primary alveolar soft part sarcoma of the rectum resected by endoscopic submucosal dissection: A case report.
Nakayama A; Yokota A; Suzuki Y; Iizuka T; Fukawa T; Ushiku T; Takazawa Y; Fujii T
Pathol Int; 2020 Aug; 70(8):581-586. PubMed ID: 32515162
[TBL] [Abstract][Full Text] [Related]
25. Crystal-deficient alveolar soft-part sarcoma with cutaneous involvement: a case report.
Kacerovska D; Michal M; Nemcova J; Vanecek T; Kreuzberg B; Mrazkova P; Koudela K; Kazakov DV
Am J Dermatopathol; 2009 May; 31(3):272-7. PubMed ID: 19384069
[TBL] [Abstract][Full Text] [Related]
26. Revisiting cytomorphology, including unusual features and clinical scenarios of 8 cases of alveolar soft part sarcoma with TFE3 immunohistochemical staining in 7 cases.
Rekhi B; Rao V; Ramadwar M
Cytopathology; 2021 Jan; 32(1):20-28. PubMed ID: 32853443
[TBL] [Abstract][Full Text] [Related]
27. [Alveolar soft part sarcoma: a clinicopathologic analysis of 48 cases].
Cheng J; Tu P; Wang J; He Y; Yu B; Rao Q; Zhou X; Shi Q
Zhonghua Bing Li Xue Za Zhi; 2016 Jan; 45(1):16-20. PubMed ID: 26791548
[TBL] [Abstract][Full Text] [Related]
28. Alveolar soft part sarcoma 'revisited': clinicopathological review of 47 cases from a tertiary cancer referral centre, including immunohistochemical expression of TFE3 in 22 cases and 21 other tumours.
Rekhi B; Ingle A; Agarwal M; Puri A; Laskar S; Jambhekar NA
Pathology; 2012 Jan; 44(1):11-7. PubMed ID: 22173238
[TBL] [Abstract][Full Text] [Related]
29. Aberrant nuclear immunoreactivity for TFE3 in neoplasms with TFE3 gene fusions: a sensitive and specific immunohistochemical assay.
Argani P; Lal P; Hutchinson B; Lui MY; Reuter VE; Ladanyi M
Am J Surg Pathol; 2003 Jun; 27(6):750-61. PubMed ID: 12766578
[TBL] [Abstract][Full Text] [Related]
30. Alveolar soft part sarcoma in a child - a case report.
Bartoš V; Sejnová D; Skálová A; Béder I
Klin Onkol; 2023; 36(4):396-400. PubMed ID: 37877532
[TBL] [Abstract][Full Text] [Related]
31. Lingual alveolar soft part sarcoma with absent TFE3 rearrangement.
Alshahrani S; Khan A
Cancer Rep (Hoboken); 2021 Feb; 4(1):e1298. PubMed ID: 33026169
[TBL] [Abstract][Full Text] [Related]
32. Significance of immunohistochemistry and FISH of TFE3 in the diagnosis of alveolar soft part sarcoma: A case report.
Huang YY; Yang WR; Geng YH; Zhang Y
Medicine (Baltimore); 2022 Jul; 101(27):e29861. PubMed ID: 35801771
[TBL] [Abstract][Full Text] [Related]
33. A case of primary alveolar soft part sarcoma of the uterine cervix and a review of the literature.
Hasegawa K; Ichikawa R; Ishii R; Oe S; Kato R; Kobayashi Y; Kuroda M; Udagawa Y
Int J Clin Oncol; 2011 Dec; 16(6):751-8. PubMed ID: 21519815
[TBL] [Abstract][Full Text] [Related]
34. Alveolar soft part sarcoma: A distinct cytomorphology and characteristic TFE3 staining.
Asiry S; Matloob A; Khader SN
Diagn Cytopathol; 2020 Jul; 48(7):684-686. PubMed ID: 32315502
[No Abstract] [Full Text] [Related]
35. Meningeal alveolar soft part sarcoma confirmed by characteristic ASPCR1-TFE3 fusion.
Bodi I; Gonzalez D; Epaliyange P; Gullan R; Fisher C
Neuropathology; 2009 Aug; 29(4):460-5. PubMed ID: 18713311
[TBL] [Abstract][Full Text] [Related]
36. Mammalian target of rapamycin pathway activity in alveolar soft part sarcoma.
Reis H; Hager T; Wohlschlaeger J; Bauer S; Katenkamp K; Katenkamp D; Baba HA
Hum Pathol; 2013 Oct; 44(10):2266-74. PubMed ID: 23871289
[TBL] [Abstract][Full Text] [Related]
37. Primary renal neoplasms with the ASPL-TFE3 gene fusion of alveolar soft part sarcoma: a distinctive tumor entity previously included among renal cell carcinomas of children and adolescents.
Argani P; Antonescu CR; Illei PB; Lui MY; Timmons CF; Newbury R; Reuter VE; Garvin AJ; Perez-Atayde AR; Fletcher JA; Beckwith JB; Bridge JA; Ladanyi M
Am J Pathol; 2001 Jul; 159(1):179-92. PubMed ID: 11438465
[TBL] [Abstract][Full Text] [Related]
38. Establishment and characterization of NCC-ASPS1-C1: a novel patient-derived cell line of alveolar soft-part sarcoma.
Yoshimatsu Y; Noguchi R; Tsuchiya R; Sei A; Sugaya J; Fukushima S; Yoshida A; Kawai A; Kondo T
Hum Cell; 2020 Oct; 33(4):1302-1310. PubMed ID: 32648033
[TBL] [Abstract][Full Text] [Related]
39. Alveolar soft part sarcoma: a clinicopathological and immunohistochemical analysis of 26 cases emphasizing risk factors and prognosis.
Zhang Y; Huang Y; Qin Y; Yang N; Yang P; Li N; Feng Z
Diagn Pathol; 2024 Jan; 19(1):23. PubMed ID: 38291475
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of TRIM63 RNA in situ hybridization (RNA-ISH) as a potential biomarker for alveolar soft-part sarcoma (ASPS).
Taylor AS; Mannan R; Pantanowitz L; Chinnaiyan AM; Dhanasekaran SM; Hrycaj S; Cao X; Chan MP; Lucas D; Wang XM; Mehra R
Med Oncol; 2024 Feb; 41(3):76. PubMed ID: 38393424
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
